Stocklytics Platform
Asset logo for symbol BDX
Becton Dickinson and Co
BDX53
$237.30arrow_drop_up1.94%$4.52
S&P500
Asset logo for symbol BDX
BDX53

$237.30

arrow_drop_up1.94%

Performance History

Chart placeholder
Key Stats
Open$234.78
Prev. Close$232.78
EPS4.68
Next Earnings DateJan 2, 2025
LOWHIGH
Day Range232.38
239.22
52 Week Range218.75
286.45
Ratios
EPS4.68

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$386.60B
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About Becton Dickinson and Co (BDX)

Becton Dickinson and Co (BDX) is a global medical technology company that specializes in the development, manufacture, and sale of medical devices, instrument systems, and reagents. The company's products are used in hospitals, clinics, laboratories, and other healthcare settings to improve patient outcomes and enhance healthcare delivery. With a rich history dating back to its founding in 1897, Becton Dickinson has established itself as a leader in the healthcare industry.
The stock price history of Becton Dickinson and Co (BDX) reflects its strong performance and growth over the years. The company has consistently delivered positive financial results and has demonstrated its ability to adapt to changing market dynamics. Investors have been rewarded with steady stock price appreciation and the payment of regular dividends.
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. Thomas E. Polen Jr.
Headquarters
Franklin Lakes
Employees
77000
Exchange
NYSE
add Becton Dickinson and Co to watchlist

Keep an eye on Becton Dickinson and Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Becton Dickinson and Co's (BDX) price per share?
The current price per share for Becton Dickinson and Co (BDX) is $237.3. The stock has seen a price change of $4.52 recently, indicating a 1.94% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Becton Dickinson and Co (BDX)?
For Becton Dickinson and Co (BDX), the 52-week high is $286.46, which is 20.72% from the current price. The 52-week low is $218.75, the current price is 8.48% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Becton Dickinson and Co (BDX) a growth stock?
Becton Dickinson and Co (BDX) has shown an average price growth of 0.41% over the past three years. It has received a score of 50 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Becton Dickinson and Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Becton Dickinson and Co (BDX) stock price performance year to date (YTD)?
As of the latest data, Becton Dickinson and Co (BDX) has a year-to-date price change of -3.31%. Over the past month, the stock has experienced a price change of 2.45%. Over the last three months, the change has been 2.48%. Over the past six months, the figure is 0.27%. Looking at a longer horizon, the five-year price change stands at -6.72%.
help
Is Becton Dickinson and Co (BDX) a profitable company?
Becton Dickinson and Co (BDX) has a net income of $1.53B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 42.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.43% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $19.37B, with a revenue growth rate of 2.66%, providing insight into the company's sales performance and growth. The gross profit is $8.17B. Operating income is noted at $2.11B. Furthermore, the EBITDA is $4.82B.
help
What is the market capitalization of Becton Dickinson and Co (BDX)?
Becton Dickinson and Co (BDX) has a market capitalization of $68.58B. The average daily trading volume is 1.27M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level